Gendius Company

Gendius was founded by Chris Genders and Rory Cameron with a view to making living with diabetes easier. The company has developed Intellin® - an App platform that uses an individual’s clinical history to predict those areas most likely of developing complications from their diabetes i.e. their individual high-risk areas. The platform then focusses the individual on clinically validated tasks and measures to slow their progression in these areas.
Industry:
Biomarkers for Longevity
Headquarters:
Chester, Cheshire, United Kingdom
Zip:
1-10
Founded Date:
2011-01-01
Employees Number:
1-10
Acquisitions Number:
3
Investors Number:
995748
Total Funding:
Less than $1M
Estimated Revenue:
Less than $1M
Last Funding Date:
Equity Crowdfunding
Last Funding Type:
roryc@gendius.co.uk
Register and Claim Ownership